Bromantane
Bromantane (Ladasten)
Bromantane (Ladasten) is an actoprotector and adaptogen developed in Russia that combines anxiolytic and mild stimulant properties without the typical trade-offs seen in classical stimulants. It is primarily used to enhance physical and mental performance, reduce fatigue, and alleviate anxiety, and was approved in Russia for the treatment of asthenic and anxiety-asthenic disorders. Unlike most nootropics, it demonstrates a notable absence of dependence potential and withdrawal effects even with prolonged use.
Mechanism of Action
Bromantane primarily enhances dopaminergic and serotonergic neurotransmission by upregulating the synthesis of key enzymes—tyrosine hydroxylase and aromatic L-amino acid decarboxylase—thereby increasing endogenous dopamine and serotonin production rather than causing direct receptor agonism or reuptake inhibition. It also potentiates GABA-A receptor activity, which accounts for its anxiolytic properties, and exhibits immunostimulatory effects. This dual dopaminergic-GABAergic profile produces stimulation without the anxiogenic or addictive properties characteristic of classical psychostimulants.
Evidence by Health Goal(13 goals)
Dosing Protocols
Morning, with or shortly after a meal to improve absorption (lipophilic compound)
Cycle: 4-8 weeks on, 2-4 weeks off
Clinical trials in Russia used 50mg and 100mg doses. Most users find 50mg sufficient; 100mg is the upper therapeutic dose used in clinical settings. Taking late in the day may cause mild sleep disruption. Start at 50mg to assess tolerance.
Safety & Side Effects
Bromantane has a favorable safety profile based on Russian clinical trials, with no significant dependence, tolerance, or withdrawal phenomena documented even with extended use; however, its reduced sweating effect poses a genuine risk of heat stroke during intense physical activity or high ambient temperatures, and long-term safety data from Western controlled trials remain limited. It is a prescription drug in Russia (Ladasten) but exists in a regulatory gray area in most Western countries, typically available as a research compound.
Possible Side Effects
- !Mild sleep disturbances or insomnia if taken too late in the day
- !Transient hyperthermia or feeling of warmth, particularly in hot environments
- !Mild gastrointestinal discomfort or nausea at higher doses
- !Headache, typically mild and resolving within the first week of use
- !Reduced sweating capacity (hypohidrosis), which may impair heat dissipation during exercise
- !Mild dizziness or lightheadedness, especially early in the course
- !Allergic skin reactions reported rarely in clinical populations
Interactions
- -May potentiate the sedative effects of benzodiazepines and other GABAergic agents due to GABA-A receptor enhancement
- -Additive dopaminergic stimulation possible when combined with other dopaminergic compounds (e.g., L-DOPA, phenylpiracetam, or dopamine reuptake inhibitors)
- -Concurrent use with stimulants (e.g., caffeine, amphetamines) may exacerbate cardiovascular strain and hyperthermia risk
- -Potential to modulate cytochrome P450 enzymes—caution advised when co-administering with narrow therapeutic index drugs metabolized by CYP3A4
- -May enhance immunostimulatory effects of other adaptogens (e.g., ashwagandha, rhodiola), though this interaction is generally benign
Cost & Where to Buy
Sold primarily through nootropics vendors and research chemical suppliers as a powder or capsule. Price varies significantly by supplier, purity, and quantity purchased; bulk powder is cheapest, while premade capsules from reputable vendors are at the higher end.
Search on Amazon